Analyzing Bausch Health Cos (NYSE:BHC) & Recordati Industria Chimica E Farmaceutica (OTCMKTS:RCDTF)Defense World · 2 days ago
Bausch Health Cos Inc. (NYSE:BHC) Stock Has Consensus Target Price of $8.00Defense World · Oct 16, 2026
Bausch Health Cos (NYSE:BHC) Shares Gap Up – What’s Next?Defense World · Oct 12, 2026
Six-Month Pilot Study Demonstrates Improved Guideline Adherence Following Implementation of Standardized Cirrhosis Clinical PathwayPRNewsWire · Oct 12, 2026
Bausch + Lomb and Bausch Health Announce Appointment of Thomas J. Appio as Interim Bausch + Lomb CEO, Expect to Raise Full-Year 2026 GuidanceBusiness Wire · Oct 12, 2026
Bausch Health to Announce Third Quarter 2026 Results on October 28, 2026PRNewsWire · Oct 6, 2026Bausch Health Companies Inc., together with its associated entities, is engaged in the development, manufacturing, and commercialization of a diverse portfolio of pharmaceutical products, medical devices, and over-the-counter remedies. Its primary therapeutic focus areas include ophthalmology, digestive health, and dermatology. The enterprise conducts its operations through five principal divisions: Bausch + Lomb, Salix, International Rx, Ortho Dermatologics, and Diversified Products.
| Date | Est. | Actual | |
|---|---|---|---|
| Jul 29, 2026 | $0.96 | $1.26 | Beat |
| Apr 29, 2026 | $0.81 | $0.78 | Miss |
| Feb 18, 2026 | $1.21 | $1.08 | Miss |
| Oct 29, 2025 | $1.07 | $1.16 | Beat |
| Jul 30, 2025 | $0.97 | $0.90 | Miss |
| Apr 30, 2025 | $0.83 | $0.59 | Miss |